Clin Oncol (R Coll Radiol). 1991 Jan;3(1):32-6.

Prechemotherapy serum CA125 level as a predictor of survival outcome in epithelial carcinoma of the ovary.

Davidson NG, Khanna S, Kirwan PH, Bircumshaw D.

Source

Department of Radiotherapy, Leicester Royal Infirmary, UK.

Abstract

A total of 55 patients with epithelial ovarian carcinoma treated with platinum-based chemotherapy were followed for a minimum period of 2 years. Of these 22 patients had a prechemotherapy serum CA125 level of less than 50 ku/l and 33 patients had a serum CA125 level of greater than or equal to 50 ku/l. The 5-year actuarial survival of the two groups were 75% and 10% respectively. Prechemotherapy CA125 level taken 4 weeks after debulking surgery may predict the eventual survival outcome in epithelial ovarian cancer patients who undergo chemotherapy treatment.

PMID:: 2001340; [PubMed - indexed for MEDLINE]

MeSH Terms, Substances

MeSH Terms

Substances

LinkOut - more resources

Medical

Libraries

LinkOut Holdings

Supplemental Content

Save items

Related citations in PubMed

Preoperative determination of several serum tumor markers in patients with primary epithelial ovarian carcinoma. [Gynecol Obstet Invest. 1999]
Preoperative determination of several serum tumor markers in patients with primary epithelial ovarian carcinoma.
Kudoh K, Kikuchi Y, Kita T, Tode T, Takano M, Hirata J, Mano Y, Yamamoto K, Nagata I. Gynecol Obstet Invest. 1999; 47(1):52-7.
Serum CA 125 level allows early identification of nonresponders during induction chemotherapy. [Gynecol Oncol. 1993]
Serum CA 125 level allows early identification of nonresponders during induction chemotherapy.
Makar AP, Kristensen GB, Børmer OP, Tropé CG. Gynecol Oncol. 1993 Apr; 49(1):73-9.
Serum CA-125 level after 6 cycles of primary adjuvant chemotherapy is a useful prognostic factor for complete responders' survival in patients with advanced epithelial ovarian cancer. [Onkologie. 2008]
Serum CA-125 level after 6 cycles of primary adjuvant chemotherapy is a useful prognostic factor for complete responders' survival in patients with advanced epithelial ovarian cancer.
Kim HS, Park NH, Chung HH, Kim JW, Song YS, Kang SB. Onkologie. 2008 Jun; 31(6):315-20. Epub 2008 May 27.
Review Medical therapy of advanced malignant epithelial tumours of the ovary. [Forum (Genova). 2000]
Review Medical therapy of advanced malignant epithelial tumours of the ovary.
Colombo N, Parma G, Bocciolone L, Franchi D, Sideri M, Maggioni A. Forum (Genova). 2000 Oct-Dec; 10(4):323-32.
Review New tumor markers: CA125 and beyond. [Int J Gynecol Cancer. 2005]
Review New tumor markers: CA125 and beyond.
Bast RC Jr, Badgwell D, Lu Z, Marquez R, Rosen D, Liu J, Baggerly KA, Atkinson EN, Skates S, Zhang Z, et al. Int J Gynecol Cancer. 2005 Nov-Dec; 15 Suppl 3:274-81.

See reviews... See all...

Cited by 2 PubMed Central articles

Longitudinal monitoring of CA125 levels provides additional information about survival in ovarian cancer. [J Ovarian Res. 2010]
Longitudinal monitoring of CA125 levels provides additional information about survival in ovarian cancer.
Gupta D, Lammersfeld CA, Vashi PG, Braun DP. J Ovarian Res. 2010 Oct 12; 3:22. Epub 2010 Oct 12.
Role of CA125 in predicting ovarian cancer survival - a review of the epidemiological literature. [J Ovarian Res. 2009]
Role of CA125 in predicting ovarian cancer survival - a review of the epidemiological literature.
Gupta D, Lis CG. J Ovarian Res. 2009 Oct 9; 2:13. Epub 2009 Oct 9.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Prechemotherapy serum CA125 level as a predictor of survival outcome in epitheli...
Prechemotherapy serum CA125 level as a predictor of survival outcome in epithelial carcinoma of the ovary.
Clin Oncol (R Coll Radiol). 1991 Jan ;3(1):32-6.

PubMed
Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non...
Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer.
Clin Cancer Res. 2009 Dec 15;15(24):7502-7509.

PubMed
Epidermal growth factor receptor expression in normal ovarian epithelium and ova...
Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. I. Correlation of receptor expression with prognostic factors in patients with ovarian cancer.
Am J Obstet Gynecol. 1991 Feb ;164(2):669-74.

PubMed
Thrombospondin-1 serum levels do not correlate with pelvic pain in patients with...
Thrombospondin-1 serum levels do not correlate with pelvic pain in patients with ovarian endometriosis.
J Ovarian Res. 2009 Nov 16 ;2(1):18.

PubMed
Gonadotrophin-releasing hormone deficiency in a mutant mouse with hypogonadism.
Gonadotrophin-releasing hormone deficiency in a mutant mouse with hypogonadism.
Nature. 1977 Sep 22 ;269(5626):338-40.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: